Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...
Healthcare Dive3d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Axios on MSN11d
FDA approves Vertex non-opioid pain drug
The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
MedCity News15d
Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds
The Vertex drug was safe and well tolerated in these studies. Vertex reported no addiction problems in the studies. Vertex is also developing Journavx for chronic pain, but there have been mixed ...
Washington Examiner on MSN13d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
(Vertex Pharmaceuticals via AP ... She pushed back, video goes nearly viral. CT has a problem with cannabis and children. Hundreds of calls to poison control illustrate it. CT has a problem with ...
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
AFP14d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 ...
Nasdaq10d
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
But Vertex now is showing that it also can be a game changer when it comes to treating one of the most common of health problems -- pain. The biotech just won regulatory approval for Journavx ...